Literature DB >> 32661835

The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis.

Eduardo Javier Barragán-Pérez1, Carlos Enrique Altamirano-Vergara1, Daniel Eduardo Alvarez-Amado2,3, Juan Carlos García-Beristain1, Fernando Chico-Ponce-de-León4, Vicente González-Carranza4, Luis Juárez-Villegas5, Chiharu Murata6.   

Abstract

There is no evidence that prolonged pre diagnostic symptomatic intervals (PSI) increases the risk of death in pediatric brain tumors. When investigating the role of time previous research had not controlled for confounding variables or measured the pretreatment interval (PTI). We use the term global delay interval (GDI) to describe the sum of PSI and PTI. The aim of this research was to evaluate whether there was a decrease in the probability of survival in children with brain tumors due to a prolonged PSI, PTI and GDI, using a multivariate survival analysis. We retrospective review 127 clinical records labeled with the diagnosis of CNS tumors attended at a specialized pediatric center in Mexico City from January 2008 to December 2012. Patients with PSI and GDI diagnosed between 3 and 6 months showed statistical lower probability of surviving that those with intervals <3 months even when adjusting for age, sex, localization and tumor grade. When stratified for the place of residency and adjusted for sex, age, localization, grade of tumor, type of surgery and coadjuvant therapy, a GDI between 3 and 6 months showed to be a risk factor for the overall survival of brain tumors compared with an interval < 3 months. When analyzing the interaction, high grade tumors are at more risk of dying when GDI was between 3 and 6 months compared to <3 months. Prolonged PSI and GDI showed to be a potential prognostic factor for survival in CNS tumors, especially in high grade tumors. Future prospective research should measure the PSI, PTI and GDI and adjust for covariates in order to properly infer the effect of time in pediatric brain tumors.

Entities:  

Keywords:  CNS tumors; Delayed diagnosis; Survival outcome; Symptomatic interval

Mesh:

Year:  2020        PMID: 32661835     DOI: 10.1007/s12253-020-00875-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   2.874


  36 in total

Review 1.  Pediatric brain tumors.

Authors:  Elizabeth M Wells; Roger J Packer
Journal:  Continuum (Minneap Minn)       Date:  2015-04

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  Diagnostic delay of pediatric brain tumors in Israel: a retrospective risk factor analysis.

Authors:  Vered Shay; Aviva Fattal-Valevski; Liana Beni-Adani; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2011-08-26       Impact factor: 1.475

4.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

5.  Does diagnostic delay result in decreased survival in paediatric brain tumours?

Authors:  Karel Kukal; Milana Dobrovoljac; Eugen Boltshauser; Roland A Ammann; Michael A Grotzer
Journal:  Eur J Pediatr       Date:  2008-06-07       Impact factor: 3.183

6.  Delayed diagnosis in children with intracranial germ cell tumors.

Authors:  Roshan V Sethi; Rose Marino; Andrzej Niemierko; Nancy J Tarbell; Torunn I Yock; Shannon M MacDonald
Journal:  J Pediatr       Date:  2013-07-26       Impact factor: 4.406

7.  Presentation of childhood CNS tumours: a systematic review and meta-analysis.

Authors:  Sophie Wilne; Jacqueline Collier; Colin Kennedy; Karin Koller; Richard Grundy; David Walker
Journal:  Lancet Oncol       Date:  2007-08       Impact factor: 41.316

Review 8.  Diagnosis delays in childhood cancer: a review.

Authors:  Tam Dang-Tan; Eduardo L Franco
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

9.  CNS germ cell tumor (CNSGCT) of childhood: presentation and delayed diagnosis.

Authors:  J R Crawford; M R Santi; G Vezina; J S Myseros; R F Keating; D A LaFond; B R Rood; T J MacDonald; R J Packer
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

10.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

View more
  1 in total

1.  Childhood Cancer Survival, 2006-2012 Cohorts of Mexican Institute of Social Security Beneficiaries at the Central-South Region of Mexico.

Authors:  Angélica Castro-Ríos; Silvia Martínez-Valverde
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.